The multidomain mobility lab in older persons: From bench to bedside

Current Pharmaceutical Design

Volumn 20, Issue 19, 2014, Pages 3093-3094

  Maggio, Marcello ^a   Ceda, Gian Paolo ^b   Lauretani, Fulvio ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

POLYUNSATURATED FATTY ACID;

ADL DISABILITY; AGED; CHRONIC DISEASE; COGNITION; DEPRESSION; DIABETIC PATIENT; DIET SUPPLEMENTATION; EDITORIAL; EPIDEMIC; GERIATRIC ASSESSMENT; GERIATRICIAN; GERIATRICS; HUMAN; PHYSICAL PERFORMANCE; POLYNEUROPATHY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SARCOPENIA; WALKING DIFFICULTY; DISABILITY; PROCEDURES;

AGED; DISABILITY EVALUATION; GERIATRIC ASSESSMENT; HUMANS; MOBILITY LIMITATION;

EID: 84903726540     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161282019140523115611     Document Type: Editorial

References (12)

1. Working Group on Functional Outcome Measures for Clinical Trials, Bhasin S, Espeland MA, Evans WJ, Ferrucci L, Fried LP, Gill TM, Pahor M, Studenski S, Guralnik J, Nayfield S, Romashkin S, Perlstein R, Burke L, Parks M. Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci. 2009; 64: 487-91.
2. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med. 1980; 303: 130-5.
3. Ellis G, Whitehead MA, Robinson D, O'Neill D, Langhorne P. Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ. 2011; 343:d6553. doi: 10.1136/bmj.d6553.
4. Zijlmans JC, Daniel SE, Hughes AJ, Révész T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord. 2004;19: 630-40.
5. Lauretani F, Bandinelli S, Bartali B, Cherubini A, Iorio AD, Blè A, Giacomini V, Corsi AM, Guralnik JM, Ferrucci L. Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons. Eur J Neurol. 2007; 14: 801-8.
6. Lauretani F, Bandinelli S, Griswold ME, Maggio M, Semba R, Guralnik JM, Ferrucci L. Longitudinal changes in BMD and bone geometry in a population-based study. J Bone Miner Res. 2008; 23: 400-8.
7. Lauretani F, Maggio M, Valenti G, Dall'Aglio E, Ceda GP. Vitamin D in older population: new roles for this 'classic actor'? Aging Male. 2010; 13: 215-32.
8. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003; 95: 1851-60.
9. Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T, Thomas DR, Anthony P, Charlton KE, Maggio M, Tsai AC, Grathwohl D, Vellas B, Sieber CC; MNA-International Group. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009; 13: 782-8.
10. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Ling SM, Metter EJ, Artoni A, Carassale L, Cazzato A, Ceresini G, Guralnik JM, Basaria S, Valenti G, Ferrucci L. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med. 2007; 167: 2249-54.
11. Buford TW, Manini TM, Hsu FC, Cesari M, Anton SD, Nayfield S, Stafford RS, Church TS, Pahor M, Carter CS. Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional response to exercise. J Am Geriatr Soc. 2012; 60:1244-52.
12. Lauretani F, Maggio M, Saccavini M, Ceda GP. Should the "Preventive Geriatric Section" be implemented in our hospital? Aging Clin Exp Res. 2008; 20: 384.